Bharat Biotech arm Nucelion to collaborate with Pandorum Tech on two PRIP-backed projects

Resumen del corpus

Bharat Biotech's subsidiary, Nucelion Therapeutics, will collaborate with Pandorum Technologies on two ophthalmic projects—one for advanced keratopathy and another for wet Age-related Macular Degeneration (wet AMD). This partnership is supported by the PRIP scheme, involving a combined investment of ₹16.97 crore. The collaboration aims to connect Pandorum's programmable regenerative medicine design with Nucelion's manufacturing capabilities to produce GMP-grade materials for clinical studies in India and abroad.